Mycoplasma hyopneumoniae evades complement activation by binding to factor H via elongation factor thermo unstable (EF-Tu)

References

• Overesch G, Kuhnert P. Persistence of Mycoplasma hyopneumoniae sequence types in spite of a control program for enzootic pneumonia in pigs. Prev Vet Med. 2017;145:67–72.
   PubMed Web of Science ®Google Scholar
• Buttenschon J, Friis NF, Aalbaek B, et al. Microbiology and pathology of fibrinous pericarditis in Danish slaughter pigs. Zentralbl Veterinarmed A. 1997;44:271–280.
   PubMedGoogle Scholar
• Le Carrou J, Laurentie M, Kobisch M, et al. Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene. Antimicrob Agents Chemother. 2006;50:1959–1966.
   PubMed Web of Science ®Google Scholar
• Woolley LK, Fell S, Gonsalves JR, et al. Evaluation of clinical, histological and immunological changes and qPCR detection of Mycoplasma hyopneumoniae in tissues during the early stages of mycoplasmal pneumonia in pigs after experimental challenge with two field isolates. Vet Microbiol. 2012;161:186–195.
   PubMed Web of Science ®Google Scholar
• Raymond BBA, Turnbull L, Jenkins C, et al. Mycoplasma hyopneumoniae resides intracellularly within porcine epithelial cells. Sci Rep. 2018;8:17697.
   PubMed Web of Science ®Google Scholar
• Kenneth Murphy CW. JANEWAY’S immunobiology. 9th ed. Vol. 2. Garland Science, Taylor & Francis Group; 2017.
   Google Scholar
• Zipfel PF. Complement factor H: physiology and pathophysiology. Semin Thromb Hemost. 2001;27:191–199.
   PubMed Web of Science ®Google Scholar
• Ferreira VP, Herbert AP, Hocking HG, et al. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J Immunol. 2006;177:6308–6316.
   PubMed Web of Science ®Google Scholar
• Weiler JM, Daha MR, Austen KF, et al. Control of the amplification convertase of complement by the plasma protein beta1H. Proc Natl Acad Sci U S A. 1976;73:3268–3272.
   PubMed Web of Science ®Google Scholar
• Kopp A, Hebecker M, Svobodova E, et al. Factor h: a complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules. 2012;2:46–75.
   PubMedGoogle Scholar
• Ram S, Sharma AK, Simpson SD, et al. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med. 1998;187:743–752.
   PubMed Web of Science ®Google Scholar
• Langford-Smith A, Day AJ, Bishop PN, et al. Complementing the Sugar Code: role of GAGs and Sialic Acid in Complement Regulation. Front Immunol. 2015;6:25.
   PubMed Web of Science ®Google Scholar
• Loh E, Kugelberg E, Tracy A, et al. Temperature triggers immune evasion by Neisseria meningitidis. Nature. 2013;502:237–240.
   PubMed Web of Science ®Google Scholar
• Hallstrom T, Zipfel PF, Blom AM, et al. Haemophilus influenzae interacts with the human complement inhibitor factor H. J Immunol. 2008;181:537–545.
   PubMed Web of Science ®Google Scholar
• Langereis JD, de Jonge MI, Weiser JN. Binding of human factor H to outer membrane protein P5 of non-typeable Haemophilus influenzae contributes to complement resistance. Mol Microbiol. 2014;94:89–106.
   PubMed Web of Science ®Google Scholar
• Rosadini CV, Ram S, Akerley BJ. Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways. Infect Immun. 2014;82:640–649.
   PubMed Web of Science ®Google Scholar
• Vaillancourt K, Bonifait L, Grignon L, et al. Identification and characterization of a new cell surface protein possessing factor H-binding activity in the swine pathogen and zoonotic agent Streptococcus suis. J Med Microbiol. 2013;62:1073–1080.
   PubMed Web of Science ®Google Scholar
• Pian Y, Gan S, Wang S, et al. Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infect Immun. 2012;80:2402–2413.
   PubMed Web of Science ®Google Scholar
• Horstmann RD, Sievertsen HJ, Knobloch J, et al. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A. 1988;85:1657–1661.
   PubMed Web of Science ®Google Scholar
• Dave S, Brooks-Walter A, Pangburn MK, et al. PspC, a pneumococcal surface protein, binds human factor H. Infect Immun. 2001;69:3435–3437.
   PubMed Web of Science ®Google Scholar
• Sadlon TA, Parker SJ, Gordon DL. Regulation of C3 deposition on gp120 coated CD4 positive cells by decay accelerating factor and factor H. Immunol Cell Biol. 1994;72:461–470.
   PubMed Web of Science ®Google Scholar
• Hutchison CA 3rd, Chuang RY, Noskov VN, et al. Design and synthesis of a minimal bacterial genome. Science. 2016;351(aad6253). DOI:https://doi.org/10.1126/science.aad6253
   Google Scholar
• Mattsson JG, Bergstrom K, Wallgren P, et al. Detection of Mycoplasma hyopneumoniae in nose swabs from pigs by in vitro amplification of the 16S rRNA gene. J Clin Microbiol. 1995;33:893–897.
   PubMed Web of Science ®Google Scholar
• Bolland JR, Simmons WL, Daubenspeck JM, et al. Mycoplasma polysaccharide protects against complement. Microbiology. 2012;158:1867–1873.
   PubMed Web of Science ®Google Scholar
• Li Q, Liu H, Du D, et al. Identification of novel laminin- and fibronectin-binding proteins by Far-Western Blot: capturing the adhesins of streptococcus suis type 2. Front Cell Infect Microbiol. 2015;5:82.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shao J, Liu G, et al. Immunoproteomic analysis of bacterial proteins of Actinobacillus pleuropneumoniae serotype 1. Proteome Sci. 2011;9:32.
   PubMed Web of Science ®Google Scholar
• Maes D, Sibila M, Kuhnert P, et al. Update on Mycoplasma hyopneumoniae infections in pigs: knowledge gaps for improved disease control. Transbound Emerg Dis. 2018;65(Suppl 1):110–124.
   PubMedGoogle Scholar
• Seo HS, Mu R, Kim BJ, et al. Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis. PLoS Pathog. 2012;8:e1002947.
   PubMed Web of Science ®Google Scholar
• Yu Y, Wang H, Wang J, et al. Elongation Factor Thermo Unstable (EF-Tu) Moonlights as an Adhesin on the Surface of Mycoplasma hyopneumoniae by Binding to Fibronectin. Front Microbiol. 2018;9:974.
   PubMed Web of Science ®Google Scholar
• Deutscher AT, Jenkins C, Minion FC, et al. Repeat regions R1 and R2 in the P97 paralogue Mhp271 of Mycoplasma hyopneumoniae bind heparin, fibronectin and porcine cilia. Mol Microbiol. 2010;78:444–458.
   PubMed Web of Science ®Google Scholar
• Wong SM, Shaughnessy J, Ram S, et al. Defining the binding region in factor H to develop a therapeutic factor H-Fc fusion protein against non-typeable haemophilus influenzae. Front Cell Infect Microbiol. 2016;6:40.
   PubMed Web of Science ®Google Scholar
• Yuzi WMJ, Bai F, Zhang X, et al. Development and application of TaqMan-BHQ real time PCR assay for detection of Mycoplasma hyopneumoniae P97. Chin Vet Sci. 2012;42:5.
   Google Scholar
• Yu Y, Liu M, Hua L, et al. Fructose-1,6-bisphosphate aldolase encoded by a core gene of Mycoplasma hyopneumoniae contributes to host cell adhesion. Vet Res. 2018;49:114.
   PubMed Web of Science ®Google Scholar
• Seymour LM, Jenkins C, Deutscher AT, et al. Mhp182 (P102) binds fibronectin and contributes to the recruitment of plasmin(ogen) to the Mycoplasma hyopneumoniae cell surface. Cell Microbiol. 2012;14:81–94.
   PubMed Web of Science ®Google Scholar
• Li Q, Ma C, Fu Y, et al. Factor H specifically capture novel Factor H-binding proteins of Streptococcus suis and contribute to the virulence of the bacteria. Microbiol Res. 2017;196:17–25.
   PubMed Web of Science ®Google Scholar
• Auger JP, Gottschalk M. The Streptococcus suis factor H-binding protein: A key to unlocking the blood-brain barrier and access the central nervous system? Virulence. 2017;8:1081–1084.
   PubMed Web of Science ®Google Scholar
• de Cordoba SR, de Jorge EG. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol. 2008;151:1–13.
   PubMed Web of Science ®Google Scholar
• Meri S, Pangburn MK. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A. 1990;87:3982–3986.
   PubMed Web of Science ®Google Scholar
• Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol. 2008;6:132–142.
   PubMed Web of Science ®Google Scholar
• Welsch JA, Ram S. Factor H and neisserial pathogenesis. Vaccine. 2008;26(Suppl 8):I40–45.
   PubMedGoogle Scholar
• Bernhard S, Fleury C, Su YC, et al. Outer membrane protein OlpA contributes to Moraxella catarrhalis serum resistance via interaction with factor H and the alternative pathway. J Infect Dis. 2014;210:1306–1310.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Asmat TM, Luo S, et al. Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J Biol Chem. 2010;285:23486–23495.
   PubMed Web of Science ®Google Scholar
• Keller LE, Jones CV, Thornton JA, et al. PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization. Infect Immun. 2013;81:173–181.
   PubMed Web of Science ®Google Scholar
• Roy D, Grenier D, Segura M, et al. Recruitment of Factor H to the streptococcus suis cell surface is multifactorial. Pathogens. 2016;5:47.
   PubMed Web of Science ®Google Scholar
• Shaughnessy J, Vu DM, Punjabi R, et al. Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic. Clin Vaccine Immunol. 2014;21:1452–1459.
   PubMed Web of Science ®Google Scholar